The main objective of this project is to develop new anti-tumour drugs aimed at inhibiting the mechanisms of blood vessel formation (angiogenesis), stopping tumour growth and inducing the death of malignant cells. This research is aimed at the synthesis, in-vitro evaluation and selection of new molecules with anti-tumour activity against glioblastomas and other tumour types with poor therapeutic efficacy.

Co-funded by the European Regional Development Fund (ERDF)